surmount trials tirzepatide Reduction of prevalence of patients meeting the criteria for metabolic syndrome with tirzepatide: a post hoc analysis from the SURPASS Clinical Trial Program | Cardiovascular Diabetology Tirzepatide - A New Dawn

Because of its strong cardiovascular data, semaglutide may be a better option for patients with cardiovascular disease, she explains

Its use can lead to bans in professional and collegiate sports

Unraveling the Impaired Incretin Effect in Obesity and Type 2 Diabetes: Key Role of Hyperglycemia-Induced Unscheduled Glycolysis and Glycolytic Overload

India is home to a culture of fat shaming and this increases the chances of abuse significantly

Unlike bariatric surgery, medical weight loss programs focus on customized plans that include nutrition counseling, lifestyle coaching, and medications to support safe and sustainable results

Aug 2025;69(15):e70065